Robert E. Ariano
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 13
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 27
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 12
-
- Pneumonia and Respiratory Infections 14
-
- Antimicrobial Resistance in Staphylococcus 10
-
- Dialysis and Renal Disease Management 9
-
- Central Venous Catheters and Hemodialysis 7
-
- Blood transfusion and management 5
- Co-authors
- Sheryl ZelenitskyG. K. M. HardingDaniel SitarGeorge G. ZhanelAdrian FineLori D WaznyJared L. CrandonDavid P. Nicolau
- Journals
- Journal of Antimicrobial Chemotherapy (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)Annals of Pharmacotherapy (6 papers)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Robert E. Ariano
72 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 118
- Applied Microbiology and Biotechnology 242
- Molecular Medicine 359
- Pharmacology 799
- Clinical Biochemistry 230
- Critical Care and Intensive Care Medicine 171
Countries citing papers authored by Robert E. Ariano
This map shows the geographic impact of Robert E. Ariano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Ariano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Ariano more than expected).
Fields of papers citing papers by Robert E. Ariano
This network shows the impact of papers produced by Robert E. Ariano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Ariano. The network helps show where Robert E. Ariano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert E. Ariano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2021 | 6 | |
| 3 | 2021 | 10 | |
| 4 | 2014 | 22 | |
| 5 | 2012 | 8 | |
| 6 | 2010 | 84 | |
| 7 | 2010 | 83 | |
| 8 | 2010 | 46 | |
| 9 | 2009 | 10 | |
| 10 | 2006 | 34 | |
| 11 | 2005 | 1 | |
| 12 | 2005 | 68 | |
| 13 | 2005 | 3 | |
| 14 | 2004 | 2 | |
| 15 | 2004 | 3 | |
| 16 | 2001 | 24 | |
| 17 | 2000 | 4 | |
| 18 | 1998 | 39 | |
| 19 | Economic impact and clinical benefits of pharmacist involvement on surgical wards. | 1995 | 13 |
| 20 | 1992 | 3 |
About Robert E. Ariano
Robert E. Ariano is a scholar working on Molecular Medicine, Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry and Pharmacology, having authored 74 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (27 papers), Pneumonia and Respiratory Infections (14 papers), Antibiotic Resistance in Bacteria (13 papers), Bacterial Identification and Susceptibility Testing (12 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Dialysis and Renal Disease Management (9 papers), Central Venous Catheters and Hemodialysis (7 papers) and Blood transfusion and management (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (242 citations), Molecular Medicine (359 citations), Pharmacology (799 citations), Clinical Biochemistry (230 citations) and Critical Care and Intensive Care Medicine (171 citations). Robert E. Ariano has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Sheryl Zelenitsky, G. K. M. Harding, Daniel Sitar, George G. Zhanel, Adrian Fine, Lori D Wazny, Jared L. Crandon, David P. Nicolau, Joseph L. Kuti and Anthony M. Nicasio. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Annals of Pharmacotherapy, Peritoneal Dialysis International and American Journal of Kidney Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.